SE9502244D0 - A composition and a process for the preparation thereof - Google Patents
A composition and a process for the preparation thereofInfo
- Publication number
- SE9502244D0 SE9502244D0 SE9502244A SE9502244A SE9502244D0 SE 9502244 D0 SE9502244 D0 SE 9502244D0 SE 9502244 A SE9502244 A SE 9502244A SE 9502244 A SE9502244 A SE 9502244A SE 9502244 D0 SE9502244 D0 SE 9502244D0
- Authority
- SE
- Sweden
- Prior art keywords
- composition
- pct
- glass
- active agent
- plasticizer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9502244A SE9502244D0 (sv) | 1995-06-20 | 1995-06-20 | A composition and a process for the preparation thereof |
US08/973,902 US6083518A (en) | 1995-06-20 | 1996-06-19 | Composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof |
DK96921197T DK0833611T3 (da) | 1995-06-20 | 1996-06-19 | Sammensætning omfattende et aktivt middel opløst i en glasdannende bærer og fremgangsmåde til fremstilling heraf |
AT96921197T ATE204466T1 (de) | 1995-06-20 | 1996-06-19 | Zusammensetzung, die ein in einem glasbildenden träger gelösten wirkstoff enthalt und ein verfahren zu deren herstellung |
AU62473/96A AU695622B2 (en) | 1995-06-20 | 1996-06-19 | A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof |
DE69614689T DE69614689T2 (de) | 1995-06-20 | 1996-06-19 | Zusammensetzung, die ein in einem glasbildenden träger gelösten wirkstoff enthalt und ein verfahren zu deren herstellung |
PT96921197T PT833611E (pt) | 1995-06-20 | 1996-06-19 | Composicao que compreendendo um agente activo dissolvido num veiculo formador de vidro e processo para a sua preparacao |
JP50378997A JP4020331B2 (ja) | 1995-06-20 | 1996-06-19 | ガラス形成性担体に溶解した活性物質からなる組成物及びその製造方法 |
DE0833611T DE833611T1 (de) | 1995-06-20 | 1996-06-19 | Zusammensetzung, die ein in einem glasbildenden träger gelösten wirkstoff enthalt und ein verfahren zu deren herstellung |
PCT/SE1996/000806 WO1997000670A1 (en) | 1995-06-20 | 1996-06-19 | A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof |
EP96921197A EP0833611B1 (en) | 1995-06-20 | 1996-06-19 | A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof |
NZ311208A NZ311208A (en) | 1995-06-20 | 1996-06-19 | Composition comprising an active agent dissolved in a glass-forming carrier comprising a glass-forming substance containing a plasticizer, composition is liquid or jelly-like below 50 degrees |
CA002225286A CA2225286C (en) | 1995-06-20 | 1996-06-19 | A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof |
ES96921197T ES2118677T3 (es) | 1995-06-20 | 1996-06-19 | Una composicion que comprende un agente activo disuelto en un vehiculo formador de vidrio y un procedimiento para su preparacion. |
ZA965237A ZA965237B (en) | 1995-06-20 | 1996-06-20 | A composition and a process for the preparation thereof |
HK98109537A HK1008774A1 (en) | 1995-06-20 | 1998-07-29 | A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9502244A SE9502244D0 (sv) | 1995-06-20 | 1995-06-20 | A composition and a process for the preparation thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9502244D0 true SE9502244D0 (sv) | 1995-06-20 |
Family
ID=20398685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9502244A SE9502244D0 (sv) | 1995-06-20 | 1995-06-20 | A composition and a process for the preparation thereof |
Country Status (15)
Country | Link |
---|---|
US (1) | US6083518A (sv) |
EP (1) | EP0833611B1 (sv) |
JP (1) | JP4020331B2 (sv) |
AT (1) | ATE204466T1 (sv) |
AU (1) | AU695622B2 (sv) |
CA (1) | CA2225286C (sv) |
DE (2) | DE69614689T2 (sv) |
DK (1) | DK0833611T3 (sv) |
ES (1) | ES2118677T3 (sv) |
HK (1) | HK1008774A1 (sv) |
NZ (1) | NZ311208A (sv) |
PT (1) | PT833611E (sv) |
SE (1) | SE9502244D0 (sv) |
WO (1) | WO1997000670A1 (sv) |
ZA (1) | ZA965237B (sv) |
Families Citing this family (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6136814A (en) * | 1997-12-08 | 2000-10-24 | Fujisawa Usa, Inc. | Aqueous acyclovir product |
SE9801705D0 (sv) * | 1998-05-14 | 1998-05-14 | Bioglan Ab | Biologically active composition |
SE9801704D0 (sv) * | 1998-05-14 | 1998-05-14 | Bioglan Ab | Biologically active composition |
US6376242B1 (en) * | 1999-09-21 | 2002-04-23 | Emory University | Methods and compositions for treating platelet-related disorders using MPL pathway inhibitory agents |
US7364752B1 (en) | 1999-11-12 | 2008-04-29 | Abbott Laboratories | Solid dispersion pharamaceutical formulations |
DE60028754T2 (de) * | 1999-11-12 | 2007-05-31 | Abbott Laboratories, Abbott Park | Feste dispersion mit ritonavir, fenofibrat oder griseofulvin |
DE10026698A1 (de) * | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
JP4512700B2 (ja) * | 2003-06-02 | 2010-07-28 | トーアエイヨー株式会社 | アシクロビル含有水溶液製剤 |
US8025899B2 (en) * | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
US20050101605A1 (en) * | 2003-11-07 | 2005-05-12 | Ahmed Salah U. | Oral liquid formulations of methotrexate |
US8900856B2 (en) | 2004-04-08 | 2014-12-02 | Biomatrica, Inc. | Integration of sample storage and sample management for life science |
WO2007062266A2 (en) | 2005-11-28 | 2007-05-31 | Marinus Pharmaceuticals | Ganaxolone formulations and methods for the making and use thereof |
GB2432528B (en) * | 2005-11-29 | 2011-04-06 | Ian Ripley | Anti-viral compositions comprising flavanone glycosides and fruit acids |
JP5160409B2 (ja) * | 2006-03-08 | 2013-03-13 | 日本農薬株式会社 | 外用の医薬組成物 |
EP2025337B1 (en) * | 2006-03-08 | 2014-09-10 | Nihon Nohyaku Co., Ltd. | Pharmaceutical composition for external use |
RU2415669C2 (ru) | 2006-03-08 | 2011-04-10 | Нихон Нохияку Ко., Лтд. | Фармацевтическая композиция для наружного применения |
EP2457560A1 (en) | 2006-06-14 | 2012-05-30 | Dr Reddy's Laboratories Limited | Topical compositions |
MX347525B (es) | 2006-09-22 | 2017-04-27 | Pharmacyclics Llc | Inhibidores de tirosina cinasa de bruton. |
KR100721126B1 (ko) | 2006-12-28 | 2007-05-23 | (주)바이오앤에이치엔티 | 모기 기피제 조성물 |
WO2009031642A1 (ja) | 2007-09-05 | 2009-03-12 | Pola Pharma Inc. | 医薬組成物 |
KR20100068271A (ko) * | 2007-09-05 | 2010-06-22 | 가부시키가이샤 폴라 파마 | 항진균 의약 조성물 |
KR20100075476A (ko) * | 2007-09-05 | 2010-07-02 | 가부시키가이샤 폴라 파마 | 항진균 조성물 |
JP5411141B2 (ja) | 2007-09-10 | 2014-02-12 | カルシメディカ,インク. | 細胞内カルシウムを調節する化合物 |
JP5421901B2 (ja) | 2008-03-31 | 2014-02-19 | 国立大学法人広島大学 | エンテロウイルス属の非エンベロープウイルスに対する抗ウイルス剤および抗ウイルス用組成物 |
GB2460915B (en) | 2008-06-16 | 2011-05-25 | Biovascular Inc | Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
MX2011002149A (es) | 2008-08-27 | 2011-04-05 | Calcimedica Inc | Compuestos que modulan el calcio intracelular. |
WO2010079373A1 (en) | 2009-01-09 | 2010-07-15 | EGIS GYOGYSZERGYAR, Nyilvánosan, Müködö | Improved pharmaceutical formulation |
JP5654497B2 (ja) * | 2009-02-13 | 2015-01-14 | トピカ ファーマシューティカルズ,インコーポレイテッド | 抗真菌製剤 |
US10130610B2 (en) | 2009-04-09 | 2018-11-20 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
EP2416758B8 (en) | 2009-04-09 | 2017-10-18 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
EP2470178B1 (en) | 2009-08-25 | 2018-10-17 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
US7718662B1 (en) | 2009-10-12 | 2010-05-18 | Pharmacyclics, Inc. | Pyrazolo-pyrimidine inhibitors of bruton's tyrosine kinase |
US20130030237A1 (en) | 2010-04-15 | 2013-01-31 | Charles Theuer | Potentiation of anti-cancer activity through combination therapy with ber pathway inhibitors |
JP6112486B2 (ja) | 2010-04-27 | 2017-04-12 | カルシメディカ,インク. | 細胞内カルシウムを調節する化合物 |
EP2563759B1 (en) | 2010-04-27 | 2022-04-06 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
EP2598660B1 (en) | 2010-07-26 | 2017-03-15 | Biomatrica, INC. | Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures |
WO2012018639A2 (en) | 2010-07-26 | 2012-02-09 | Biomatrica, Inc. | Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures |
US9079891B2 (en) | 2010-08-27 | 2015-07-14 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
US8377946B1 (en) | 2011-12-30 | 2013-02-19 | Pharmacyclics, Inc. | Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors |
WO2014059333A1 (en) | 2012-10-12 | 2014-04-17 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
EP3249054A1 (en) | 2012-12-20 | 2017-11-29 | Biomatrica, INC. | Formulations and methods for stabilizing pcr reagents |
US9611263B2 (en) | 2013-10-08 | 2017-04-04 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
EP3077388A1 (en) | 2013-12-05 | 2016-10-12 | Pharmacyclics, LLC | Inhibitors of bruton's tyrosine kinase |
WO2015120389A1 (en) | 2014-02-10 | 2015-08-13 | Patara Pharma, LLC | Mast cell stabilizers treatment for systemic disorders |
CN106535889A (zh) | 2014-02-10 | 2017-03-22 | 帕塔拉制药有限责任公司 | 用于治疗肺疾病的肥大细胞稳定剂 |
WO2015164213A1 (en) | 2014-04-23 | 2015-10-29 | The Research Foundation For The State University Of New York | A rapid and efficient bioorthogonal ligation reaction and boron-containing heterocycles useful in conjuction therewith |
CN113826612B (zh) | 2014-06-10 | 2022-11-22 | 生物马特里卡公司 | 在环境温度下稳定凝血细胞 |
US9839644B2 (en) | 2014-09-09 | 2017-12-12 | ARKAY Therapeutics, LLC | Formulations and methods for treatment of metabolic syndrome |
US9359316B1 (en) | 2014-11-25 | 2016-06-07 | Concentric Analgesics, Inc. | Prodrugs of phenolic TRPV1 agonists |
US10227333B2 (en) | 2015-02-11 | 2019-03-12 | Curtana Pharmaceuticals, Inc. | Inhibition of OLIG2 activity |
AU2016225000B2 (en) | 2015-02-27 | 2021-04-01 | Curtana Pharmaceuticals, Inc. | Inhibition of Olig2 activity |
US10265296B2 (en) | 2015-08-07 | 2019-04-23 | Respivant Sciences Gmbh | Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders |
EP3331522A1 (en) | 2015-08-07 | 2018-06-13 | Patara Pharma LLC | Methods for the treatment of mast cell related disorders with mast cell stabilizers |
CN113588501A (zh) | 2015-12-08 | 2021-11-02 | 生物马特里卡公司 | 降低红细胞沉降速率 |
US10851123B2 (en) | 2016-02-23 | 2020-12-01 | Concentric Analgesics, Inc. | Prodrugs of phenolic TRPV1 agonists |
AU2017263574B2 (en) | 2016-05-12 | 2022-11-17 | The Regents Of The University Of Michigan | ASH1L inhibitors and methods of treatment therewith |
CA3025268A1 (en) | 2016-05-25 | 2017-11-30 | Concentric Analgesics, Inc. | Prodrugs of phenolic trpv1 agonists in combination with local anesthetics and vasoconstrictors for improved local anesthesia |
WO2017205769A1 (en) | 2016-05-27 | 2017-11-30 | Pharmacyclics Llc | Inhibitors of interleukin-1 receptor-associated kinase |
WO2017205762A1 (en) | 2016-05-27 | 2017-11-30 | Pharmacyclics Llc | Inhibitors of interleukin-1 receptor-associated kinase |
WO2017205766A1 (en) | 2016-05-27 | 2017-11-30 | Pharmacyclics Llc | Inhibitors of interleukin-1 receptor-associated kinase |
CN109843868A (zh) | 2016-08-26 | 2019-06-04 | 科泰纳制药公司 | Olig2活性的抑制 |
EP3506893A4 (en) | 2016-08-31 | 2020-01-22 | Respivant Sciences GmbH | CROMOLYNE COMPOSITIONS FOR THE TREATMENT OF CHRONIC COUGH DUE TO IDIOPATHIC PULMONARY FIBROSIS |
EP3522983A4 (en) | 2016-10-07 | 2020-06-03 | Respivant Sciences GmbH | CROMOLYNE-BASED COMPOSITIONS FOR THE TREATMENT OF PULMONARY FIBROSIS |
WO2019094434A1 (en) | 2017-11-07 | 2019-05-16 | The Regents Of The University Of Michigan | Therapeutic combination for treatment of cerebellar ataxia |
CA3082077A1 (en) | 2017-11-10 | 2019-05-16 | The Regents Of The University Of Michigan | Ash1l degraders and methods of treatment therewith |
CA3084809A1 (en) | 2017-12-07 | 2019-06-13 | The Regents Of The University Of Michigan | Nsd family inhibitors and methods of treatment therewith |
US11685722B2 (en) | 2018-02-28 | 2023-06-27 | Curtana Pharmaceuticals, Inc. | Inhibition of Olig2 activity |
CN112533581A (zh) | 2018-06-07 | 2021-03-19 | 密歇根大学董事会 | Prc1抑制剂及用其进行治疗的方法 |
TW202019887A (zh) | 2018-07-27 | 2020-06-01 | 美商同心止痛劑股份有限公司 | 酚系trpv1促效劑之聚乙二醇化前藥 |
GB2591681A (en) | 2018-08-29 | 2021-08-04 | Ftf Pharma Private Ltd | Methotrexate pharmaceutical composition |
US20200069742A1 (en) | 2018-08-29 | 2020-03-05 | Myos Rens Technology Inc. | Methods for alleviating, inhibiting or reversing muscle disuse atrophy in mammals |
US20200108102A1 (en) | 2018-10-03 | 2020-04-09 | Myos Rens Technology Inc. | Spray dried follistatin product |
CN113382753A (zh) * | 2018-10-24 | 2021-09-10 | 瑟拉诺沃有限公司 | 用于口服药物制剂的深共晶溶剂平台 |
NL2021864B1 (en) * | 2018-10-24 | 2020-05-13 | Seranovo B V | Deep Eutectic Solvent Platform for Oral Pharmaceutical Formulations |
US10925904B2 (en) | 2018-11-06 | 2021-02-23 | Myos Rens Technology, Inc. | Methods and compositions for improving skeletal muscle protein fractional synthetic rate |
AU2019417833A1 (en) | 2018-12-31 | 2021-06-24 | Biomea Fusion, Inc. | Irreversible inhibitors of menin-MLL interaction |
US11833186B2 (en) | 2019-02-01 | 2023-12-05 | Myos Corp. | Methods and compositions for improving quality of life and increasing activity in aging and chronically ill mammals |
WO2020190890A1 (en) | 2019-03-15 | 2020-09-24 | Unicycive Therapeutics Inc. | Nicorandil derivatives |
US11858925B2 (en) | 2020-07-10 | 2024-01-02 | The Regents Of The University Of Michigan | GAS41 inhibitors and methods of use thereof |
EP4263542A1 (en) | 2020-12-16 | 2023-10-25 | Biomea Fusion, Inc. | Fused pyrimidine compounds as inhibitors of menin-mll interaction |
US20230120115A1 (en) | 2021-08-11 | 2023-04-20 | Biomea Fusion, Inc. | Covalent inhibitors of menin-mll interaction for diabetes mellitus |
WO2023027966A1 (en) | 2021-08-24 | 2023-03-02 | Biomea Fusion, Inc. | Pyrazine compounds as irreversible inhibitors of flt3 |
WO2023039240A1 (en) | 2021-09-13 | 2023-03-16 | Biomea Fusion, Inc. | IRREVERSIBLE INHIBITORS OF KRas |
WO2023086341A1 (en) | 2021-11-09 | 2023-05-19 | Biomea Fusion, Inc. | Inhibitors of kras |
TW202340177A (zh) | 2021-12-30 | 2023-10-16 | 美商拜歐米富士恩股份有限公司 | 作為 flt3抑制劑之吡嗪化合物 |
WO2023235618A1 (en) | 2022-06-03 | 2023-12-07 | Biomea Fusion, Inc. | Fused pyrimidine compounds as inhibitors of menin |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US33221A (en) * | 1861-09-03 | Improvement in soap | ||
US4151273A (en) * | 1974-10-31 | 1979-04-24 | The Regents Of The University Of California | Increasing the absorption rate of insoluble drugs |
USRE33221E (en) | 1982-04-29 | 1990-05-22 | American Dental Association Health Foundation | Dental restorative cement pastes |
US5389677B1 (en) * | 1986-12-23 | 1997-07-15 | Tristrata Inc | Method of treating wrinkles using glycalic acid |
US4938964A (en) * | 1987-12-09 | 1990-07-03 | Showa Denko Kabushiki Kaisha | External dermatological composition |
US5215757A (en) * | 1991-03-22 | 1993-06-01 | The Procter & Gamble Company | Encapsulated materials |
US5162117A (en) * | 1991-11-22 | 1992-11-10 | Schering Corporation | Controlled release flutamide composition |
SG43179A1 (en) * | 1991-12-18 | 1997-10-17 | Warner Lambert Co | A process for the prepatation of a solid dispersion |
US5340591A (en) * | 1992-01-24 | 1994-08-23 | Fujisawa Pharmaceutical Co., Ltd. | Method of producing a solid dispersion of the sparingly water-soluble drug, nilvadipine |
-
1995
- 1995-06-20 SE SE9502244A patent/SE9502244D0/sv unknown
-
1996
- 1996-06-19 CA CA002225286A patent/CA2225286C/en not_active Expired - Lifetime
- 1996-06-19 NZ NZ311208A patent/NZ311208A/xx not_active IP Right Cessation
- 1996-06-19 EP EP96921197A patent/EP0833611B1/en not_active Expired - Lifetime
- 1996-06-19 AU AU62473/96A patent/AU695622B2/en not_active Expired
- 1996-06-19 AT AT96921197T patent/ATE204466T1/de active
- 1996-06-19 WO PCT/SE1996/000806 patent/WO1997000670A1/en active IP Right Grant
- 1996-06-19 PT PT96921197T patent/PT833611E/pt unknown
- 1996-06-19 DK DK96921197T patent/DK0833611T3/da active
- 1996-06-19 ES ES96921197T patent/ES2118677T3/es not_active Expired - Lifetime
- 1996-06-19 US US08/973,902 patent/US6083518A/en not_active Expired - Lifetime
- 1996-06-19 DE DE69614689T patent/DE69614689T2/de not_active Expired - Lifetime
- 1996-06-19 DE DE0833611T patent/DE833611T1/de active Pending
- 1996-06-19 JP JP50378997A patent/JP4020331B2/ja not_active Expired - Lifetime
- 1996-06-20 ZA ZA965237A patent/ZA965237B/xx unknown
-
1998
- 1998-07-29 HK HK98109537A patent/HK1008774A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PT833611E (pt) | 2002-01-30 |
ATE204466T1 (de) | 2001-09-15 |
DE69614689D1 (de) | 2001-09-27 |
HK1008774A1 (en) | 1999-05-21 |
US6083518A (en) | 2000-07-04 |
ES2118677T3 (es) | 2001-10-16 |
ES2118677T1 (es) | 1998-10-01 |
AU6247396A (en) | 1997-01-22 |
DK0833611T3 (da) | 2001-10-08 |
CA2225286A1 (en) | 1997-01-09 |
NZ311208A (en) | 1999-03-29 |
WO1997000670A1 (en) | 1997-01-09 |
EP0833611A1 (en) | 1998-04-08 |
DE833611T1 (de) | 1999-01-07 |
ZA965237B (en) | 1997-01-09 |
AU695622B2 (en) | 1998-08-20 |
DE69614689T2 (de) | 2002-06-27 |
EP0833611B1 (en) | 2001-08-22 |
CA2225286C (en) | 2003-06-10 |
JP4020331B2 (ja) | 2007-12-12 |
JPH11508250A (ja) | 1999-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9502244D0 (sv) | A composition and a process for the preparation thereof | |
NO964939L (no) | Fremgangsmåte for fremstilling av virkestoffpreparater i form av en fast lösning av virkestoffet i en polymermatriks, samt virkestoffpreparater fremstilt ved hjelp av denne fremgangsmåte | |
FI103091B1 (sv) | Förfarande för framställning av en sammansättning med fördröjd frigöring | |
EP0736041A4 (en) | TRANSPARENT LIQUID FOR ADMINISTRATIVE ADMINISTRATION | |
MY121192A (en) | New compounds. | |
IL115920A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING omega-SUBSTITUTED 2,2-DICHLOROALKANECARBOXYLIC ACIDS, SOME SUCH NEW COMPOUNDS AND PROCESS FOR THEIR PREPARATION | |
IS3966A (is) | Aðferð til framleiðslu á lyfjablöndum sem innihalda nifedipine | |
NO973646D0 (no) | Orale doseringsformer inneholdende et <beta>-laktam antibiotikum | |
ATE237316T1 (de) | Ibuprofen und domperidone enthaltende pharmazeutische zusammensetzungen | |
SE9403389D0 (sv) | Pharmaceutical composition containing derivattves of sex hormones | |
NZ508074A (en) | Biologically active compositions, and methods for their preparation, comprising a carrier matrix supersaturated with active agent | |
ATE175870T1 (de) | Pharmazeutische zubereitung zur rektalen verabreichung von pharmakologisch wirksamen verbindungen | |
ATE19472T1 (de) | Verwendung von 5-phenyl-1,4-benzodoazepinen zur herstellung von analgetisch wirksamen pharmazeutischen zubereitungen. | |
EP0305194A3 (en) | Veterinary composition | |
GT198700016A (es) | Procedimiento para la preparacion de n benzoil -n'-fenilu--reas. | |
IL117734A (en) | Anellated beta-carbolines their preparation and pharmaceutical compositions containing them |